The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. “The...

Researchers have shown that the glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death for people with type 2 diabetes. These...

By

HIV infection is the leading risk factor for stroke in young African adults, a new study by the University of Liverpool’s Institute of Infection and Global Health has found. The incidence of stroke...

By

More than half of Asian Americans and nearly half of Hispanic Americans with diabetes are undiagnosed, according to researchers from the National Institutes of Health and the Centers for Disease Control...

By

A 20-year study by James Cook University scientists has found a strong link between diabetes and tuberculosis in tropical Australia. Despite massive improvements in sanitation and antibiotic coverage...

By

Congressman Markwayne Mullin (R-OK) and Congressman Donald Payne, Jr. (D-NJ) have joined together in a bi-partisan effort to improve the health and wellbeing of men and boys by co-chairing the newly reauthorized Congressional...

By

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis...

Researchers from the Weizmann Institute of Science in Israel and their colleagues demonstrated how artificial sweeteners can disrupt the regulation of glucose tolerance, causing concern that the tasty...